A World Without Reps—How to Survive if Doctors Ever Completely Deny Access

The rep-centered pharmaceutical commercialization landscape is evolving. Overwhelmed healthcare professionals (HCPs) are gravitating towards ...

Zoom In, Zoom Out: How to Make Commercial Inroads at Health Systems

As health systems continue to vertically integrate and consolidate, their buying power increases, setting ...

This Time It’s Personal—The Key to Improving HCP Engagements

Healthcare professionals (HCPs) want a more personal touch from pharma. According to Sermo’s HCP ...

Two Key Questions About HCP Engagement and Education in 2023

PM360 asked experts in engaging healthcare providers what strategies work best now following the ...

Three Reporting UX Strategies to Maximize Sales Force Success

Strategic reporting efforts are fundamental to support sales force efficiency and effectiveness. Biopharma companies ...

The Imperative for KAM in Pharma

Over the past decade, macro trends in healthcare have pushed life sciences companies to ...

What Physicians Want from Pharma—And Where—During Diagnosis and Treatment

For life sciences commercial teams, effectively engaging physicians and supporting them with education on ...

Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why

According to a 2021 study by Statista, 40% of prescriptions written in 2005 were ...

Mindshift: Preparing the New, Truly Hybrid Salesforce

In his heyday, the pharma and life sciences sales representative enjoyed a level of ...

Reshaping Commercial Operations for COVID-Era Launch Success

Healthcare professionals’ jobs have become more difficult during the COVID-19 pandemic. In-person interactions with ...

4 Imperatives to Optimize the Pharma Sales Team in 2022

As pharma commercial and marketing teams plan for 2022 and examine their sales forces ...

Breaking the Rep Factory—There Is a Better Way

How can you as a pharma leader break the “rep factory” cycle to drive ...